Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Nevada
Payment figures include all payments received during the 2018 calendar year.
Payments in 2018
Drugs & Devices
Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). The top 100 products, based on total dollar amount of payments, are displayed.
Top Drugs
| Product | Product Type | Payments |
|---|---|---|
FARXIGA |
drug |
$246K |
INVOKANA |
drug |
$222K |
XIIDRA |
drug |
$185K |
OTEZLA |
drug |
$170K |
HUMIRA |
drug |
$127K |
TECENTRIQ |
drug |
$126K |
TRULICITY |
drug |
$125K |
EUCRISA |
drug |
$124K |
XARELTO |
drug |
$123K |
DUPIXENT |
drug |
$114K |
Top Devices
| Product | Product Type | Payments |
|---|---|---|
POLARIS POSTERIOR SPINAL SYSTEM |
device |
$1.61M |
JOURNEY II CR |
device |
$1.1M |
JOURNEY II BCS |
device |
$870K |
DA VINCI SURGICAL SYSTEM |
device |
$686K |
VITALITY |
device |
$637K |
MPO MEDIAL PIVOT KNEE |
device |
$428K |
XLIF |
device |
$272K |
NATRELLE |
device |
$247K |
SET AND RAINBOW SET |
device |
$237K |
MIDLINE II |
device |
$181K |
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.